Operating income decreased 31.5%
Operating income changed -31.5% from the comparable as-filed period.
-$3.5M→-$4.6M0 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PMI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 852 bp higher
Operating margin changed +852 basis points from the comparable as-filed period.
-165.23%→-156.70%0 prior comparisons
Revenue increased 38.6%
Revenue changed +38.6% from the comparable as-filed period.
$2.1M→$3.0M0 prior comparisons
Gross margin moved 2681 bp higher
Gross margin changed +2681 basis points from the comparable as-filed period.
-5.96%→20.85%0 prior comparisons
Research & development increased 84.9%
Research & development changed +84.9% from the comparable as-filed period.
$743,000→$1.4M0 prior comparisons
Cash & equivalents decreased 90.7%
Cash & equivalents changed -90.7% from the comparable as-filed period.
$410,000→$38,0000 prior comparisons
Current liabilities decreased 83.7%
Current liabilities changed -83.7% from the comparable as-filed period.
$45.6M→$7.5M0 prior comparisons
Selling, general & administrative increased 46.0%
Selling, general & administrative changed +46.0% from the comparable as-filed period.
$2.7M→$3.9M0 prior comparisons
Shares outstanding decreased 96.8%
Shares outstanding changed -96.8% from the comparable as-filed period.
73,701,176→2,338,6340 prior comparisons
Inventory / revenue moved 12620 bp lower
Inventory / revenue changed -12620 basis points from the comparable as-filed period.
328.30%→202.10%0 prior comparisons
Total assets decreased 21.7%
Total assets changed -21.7% from the comparable as-filed period.
$11.7M→$9.2M0 prior comparisons
Current assets decreased 21.3%
Current assets changed -21.3% from the comparable as-filed period.
$9.6M→$7.6M0 prior comparisons
Current ratio increased 382.2%
Current ratio changed +382.2% from the comparable as-filed period.
0.21→1.020 prior comparisons
R&D / revenue moved 1165 bp higher
R&D / revenue changed +1165 basis points from the comparable as-filed period.
34.87%→46.51%0 prior comparisons
Working capital / assets moved 30909 bp higher
Working capital / assets changed +30909 basis points from the comparable as-filed period.
-307.55%→1.54%0 prior comparisons
Inventory decreased 14.7%
Inventory changed -14.7% from the comparable as-filed period.
$7.0M→$6.0M0 prior comparisons
Gross profit changed across a sign change
Gross profit changed +585.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$127,000→$616,0000 prior comparisons
Working capital changed across a sign change
Working capital changed +100.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$36.0M→$141,0000 prior comparisons
Cost of revenue increased 3.5%
Cost of revenue changed +3.5% from the comparable as-filed period.
$2.3M→$2.3M0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.